Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $196.65 USD
Change Today +3.55 / 1.84%
Volume 919.2K
BCR On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christopher S. Holland

Chief Financial Officer and Senior Vice President, CR Bard Inc.
AgeTotal Calculated CompensationThis person is connected to 10 board members in 3 different organizations across 19 different industries.

See Board Relationships
49$3,642,668
As of Fiscal Year 2014

Background*

Mr. Christopher S. Holland, also known as Chris, has been Vice President of Rochester Medical Corporation since November 14, 2013. Mr. Holland has been the Chief Financial Officer and Senior Vice President at CR Bard Inc. since May 21, 2012. Mr. Holland served as the President, Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer and Treasurer of various companies associated with ARAMARK Corporation. He served as the Principal Financial ...

Read Full Background

Corporate Headquarters*

730 Central Avenue
Murray Hill, New Jersey 07974

United States

Phone: 908-277-8000
Fax: 908-277-8412

Board Members Memberships*

Director
Director
2013-Present
Vice President and Director

Education*

BA
Drew University
MBA
New York University

Other Affiliations*

Annual Compensation*

Salary$594,500
Total Annual Compensation$594,500

Stock Options*

Restricted Stock Awards$1,341,966
All Other Compensation$436,359
Exercisable Options25,839
Exercisable Options Value$1,564,726
Unexercisable Options56,565
Unexercisable Options Value$1,924,409
Total Value of Options$3,489,134
Total Number of Options82,404

Total Compensation*

Total Annual Cash Compensation$1,624,077
Total Short Term Compensation$594,500
Other Long Term Compensation$1,778,325
Total Calculated Compensation$3,642,668
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BCR:US $196.65 USD +3.55

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer, President and Director
Endo International plc
$1.1M
Olivier Bohuon Chief Executive Officer, Director, Chairman of Disclosures Committee, Chairman of Executive Risk Committee and Member of Nomination & Governance Committee
Smith & Nephew plc
$3.2M
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
$1.0M
Michael A. Mussallem Chairman and Chief Executive Officer
Edwards Lifesciences Corp.
$900.0K
Lars Rasmussen B.Sc (Eng), MBAChief Executive Officer and President
Coloplast A/S
kr8.7M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CR BARD INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.